NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, NEW ZEALAND, HONG KONG, JAPAN, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL, BE SUBJECT TO LEGAL RESTRICTIONS OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES.
The exercise period of Northgold AB’s (“Northgold” or the “Company”) warrants of series TO2, which were issued in connection with the rights issue of units carried out by the Company in September 2024, begins today, and lasts until 14 April 2025. Each warrant of series TO2 entitles the holder to subscribe for one (1) new share in Northgold at a price of SEK 1.20 per share. In the event of full utilisation of the warrants of series TO2, the Company will receive approximately SEK 6.1 million before issue costs.
In September 2024, Northgold carried out a rights issue which provided the Company with approximately SEK 7.6 million before the repayment of a bridge loan of SEK 1.3 million and issue costs. Through the rights issue, 5,070,192 warrants of series TO2 were issued. Each warrant of series TO2 entitles the holder to subscribe for one (1) new share in Northgold during the exercise period from 1 April 2025 to 14 April 2025. The exercise price for the warrants of series TO2 has been set at SEK 1.20 per share. In the event of full utilisation of the warrants of series TO2, approximately SEK 6.1 million will be provided to the Company before issue costs.
Warrants of series TO2 in short
- Subscription price: Each warrant of series TO2 entitles the warrant holder to subscribe for one (1) new share in Northgold at a price of SEK 1.20 per share.
- Issue volume: In total, 5,070,192 warrants of series TO2 were issued, which upon full utilisation would provide Northgold with SEK 6.1 million before issue costs.
- Number of outstanding shares prior to warrant exercise: 22,815,862 shares.
- Short name and ISIN: The warrants of series TO2 are traded on Nasdaq First North Growth Market under short name “NG TO2” and with ISIN SE0022759197.
The full terms and conditions of the warrants of series TO2 are available on the Company’s website, www.northgoldab.com.
Important dates
- 1 April 2025: Exercise period commences.
- 9 April 2025: Last day of trading in warrants of series TO2.
- 14 April 2025: Exercise period ends.
Shares and share capital
Upon full utilisation of the warrants of series TO2, the number of shares in Northgold will increase by 5,070,192 shares to a total of 27,886,054 shares and the share capital will increase by SEK 357,054.774846 to SEK 1,963,801.120806. The dilution at full utilisation amounts to approximately 18.2 per cent of the capital and votes.
Additional information
For further information, please contact:
Seppo Tuovinen, CEO, +358 504 109 625
Email: ir@northgoldab.com
About Northgold
Northgold is a Swedish-listed gold exploration and development Company focused on advancing multiple, co-located, resource-stage projects in the Middle Ostrobothnia Gold Belt (MOGB) of Central Finland, including the Kopsa Gold-Copper project, the Kiimala Trend Gold project, and the Hirsikangas Gold project. The Company strives to grow its gold mineral resources, make new gold discoveries, and ultimately extract gold from these under-explored areas in Central Finland.www.northgoldab.com. Augment Partners AB, tel. +46 8-604 22 55 info@augment.se, is acting as the Company's Certified Adviser.
Important information
Publication or distribution of this press release may in some jurisdictions be subject to statutory and legal restrictions and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and observe such restrictions. The information in this press release does not constitute an offer to acquire, subscribe or otherwise trade in shares or other securities in Northgold.
This press release does not constitute an offer to acquire securities in the United States. The securities mentioned herein may not be sold in the United States without registration in accordance with The Securities Act of 1933 or without the application of an exception to such registration. The information in this press release may not be released, published, reproduced or distributed in or to the United States, Australia, Belarus, Canada, New Zealand, Hong Kong, Japan, Russia, Switzerland, Singapore, South Africa, or any other country or jurisdiction where such action is not permitted or such action is subject to legal restrictions or would require further registration or other measures than required by Swedish law. Measures contrary to this instruction may constitute a breach of applicable securities laws.
